XASX
REG
Market cap1.32bUSD
Jul 10, Last price
6.32AUD
1D
0.16%
1Q
2.10%
Jan 2017
37.99%
IPO
58.00%
Name
Regis Healthcare Ltd
Chart & Performance
P/E
39.04
P/S
1.66
EPS
0.16
Div Yield, %
2.57%
Shrs. gr., 5y
0.20%
Rev. gr., 5y
11.59%
Revenues
1.15b
+13.68%
Net income
49m
P
CFO
306m
+21.33%
Dividend
Sep 09, 20250.0813 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Regis Healthcare Limited is a leading Australian provider specializing in comprehensive care services for the elderly. The company operates a network of residential aged care facilities and delivers a broad spectrum of in-home support. These home-based offerings include personal assistance such as hygiene and mobility, rehabilitation, and practical aid with household tasks like cleaning, cooking, and shopping, along with transportation and social outings. Regis also offers companionship and manages both government-funded and private home care programs. Additionally, the company owns and operates specialized retirement and independent living villages, providing residents with services including laundry, meals, cleaning, and access to allied health professionals for physiotherapy, podiatry, diversional therapy, and other therapeutic programs. Its aged care portfolio covers long-term 'ageing-in-place' solutions, short-term respite breaks, specialized dementia care, and dignified palliative care. The company further extends its services to in-home disability support and veterans' home care, offers therapeutic interventions for community members, retirement village residents, and those in low care homes, and manages Day Respite centres. As of mid-2022, Regis Healthcare Limited managed 64 residential aged care homes. Established in 1994, the company was formerly named Fairway Investment Holdings Pty Ltd before adopting its current name in 2014, and its main office is located in Armadale, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||